Evidence map›Paper›PMID 22397921›Full record

ArticlePsychiatry research2012

Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia.

Bin Tang, Cristina Capitao, Brian Dean, Elizabeth A Thomas

Open access · greenAbstract read
In one paragraph

Article in Psychiatry research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders.Advances in experimental medicine and biology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Bin TangDepartment of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Cristina Capitao
Brian Dean
Elizabeth A Thomas
Scripps Research Institute · USMental Health Research Institute · AU

Funding

Towards Mechanistic Explanations of Striatal DisordersR01NS044169 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI THOMAS, ELIZABETH A · 2002 to 2010
$2.4M
Schizophrenia: Molecular Markers of Disease ProgressionR01MH069696 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI THOMAS, ELIZABETH A · 2004 to 2008
$1.5M
NIMH NIH HHS MH069696NIMH NIH HHS R01 MH069696NINDS NIH HHS NS44169NINDS NIH HHS R01 NS044169
6 · The paper itself

Abstract

We have previously identified differential effects of age on global brain gene expression profiles in subjects with schizophrenia compared to normal controls. Here, we have focused on age-related effects of genes associated with the arachidonic acid-related inflammation pathway. Linear correlation analysis of published microarray expression data reveal strong age- and cell-type- specific-effects on the expression of genes related to the arachidonic acid signaling pathway, which differed in control subjects compared to those with schizophrenia. Using real-time qPCR analysis, we validated age and disease effects of arachidonic acid-related genes in a large cohort of subjects with schizophrenia and matched controls (n=76 subjects in total). We found that levels of prostaglandin-endoperoxide synthase 1 (PTGS1; aka COX-1) and prostaglandin-endoperoxide receptor 3 (PTGER3) mRNA are increased, and levels of prostaglandin-endoperoxide synthase 2 (PTGS2; aka COX-2) mRNA are decreased, in older subjects with schizophrenia (> 40years of age) compared to matched normal controls or younger subjects with schizophrenia (< 40years of age). These findings contribute to the accumulating evidence suggesting that inflammatory processes in the CNS contribute to pathophysiology of schizophrenia and further suggest that age may be an important factor in the potential use of anti-inflammatory therapies.

Indexed as

AgingAdolescentAdultAgedAged, 80 and overAntipsychotic AgentsArachidonic AcidCohort StudiesCyclooxygenase 1Cyclooxygenase 2FemaleGene Expression ProfilingGene Expression RegulationHumansLinear ModelsMaleAntipsychotic AgentsArachidonic AcidCyclooxygenase 1Cyclooxygenase 2PTGER3 protein, humanPTGS1 protein, humanPTGS2 protein, humanReceptors, Prostaglandin E, EP3 SubtypeRNA, Messenger

Identifiers

PMID22397921
PMCPMC3361581
OpenAlexW2071779278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.